Phoebe loh qiagen
Webbför 18 timmar sedan · QIAGEN N.V., eine niederländische Holdinggesellschaft, ist der weltweit führende Anbieter von Komplettlösungen zur Gewinnung wertvoller molekularer Erkenntnisse aus biologischen Proben. Die... Webb14 apr. 2024 · 20-F. Weitere Informationen finden Sie in Berichten, die QIAGEN bei der U.S. Securities and Exchange Commission (US-Börsenaufsichtsbehörde) eingereicht hat. Kontakte QIAGEN: Investor Relations Public Relations. John Gilardi +49 2103 29 11711 Thomas Theuringer +49 2103 29 11826. Phoebe Loh +49 2103 29 11457 Daniela Eltrop …
Phoebe loh qiagen
Did you know?
Webb7 juli 2024 · QIAGEN N.V. to Release Results for Q2 2024 and Hold Webcast. VENLO, Netherlands-- (BUSINESS WIRE)-- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock … Webb21 okt. 2024 · Email: [email protected]. Phoebe Loh Senior Director Investor Relations +49 2103 29 11457 Email: [email protected]
Webb30 juni 2024 · QIAGEN Investor Relations John Gilardi +49 2103 29 11711 Phoebe Loh +49 2103 29 11457 e-mail: [email protected] Public Relations Thomas Theuringer +49 2103 29 11826 Robert Reitze +49 2103 29... WebbQIAGEN Investor Relations John Gilardi +49 2103 29 11711 Phoebe Loh +49 2103 29 11457 [email protected]. Public Relations Thomas Theuringer +49 2103 29 11826 Robert …
WebbView Phoebe Loh’s profile on LinkedIn, the world’s largest professional community. Phoebe has 4 jobs listed on their profile. See the complete profile on LinkedIn and discover … Webb14 mars 2024 · March 14, 2024 GERMANTOWN, Md. & HILDEN, Germany-- (BUSINESS WIRE)-- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today …
Webbför 18 timmar sedan · QIAGEN präsentiert neueste Technologien für die Krebsforschung beim Jahrestreffen der American Association for Cancer Research. ... John Gilardi Phoebe Loh +49 2103 29 11711 +49 2103 29 11457:
WebbPhoebe Loh. DIRECTOR INVESTOR RELATIONS +49 2103 29 11457. [email protected]. Send Mail. Alexandra Koenig. INVESTOR RELATIONS … the powers that be piercing vancouverWebb15 nov. 2024 · On November 15, 2024, QIAGEN N.V. (NYSE: QGEN; Frankfurt, Prime Standard: QIA) issued a press release announcing it has begun a review of potential strategic alternatives. The press release is furnished herewith as Exhibit 99.1 and is incorporated by reference herein. 3. ... [email protected] ... the powers that be angelWebbNeuMoDx™ plans to deliver 11 CE-IVD assays to QIAGEN by the end of 2024 on NeuMoDx™ System as part of aggressive menu expansion plans, including blood-borne viruses, ... Phoebe Loh. Phone number: +49 2103 29 11457. Email: [email protected] . Public Relations. Thomas Theuringer. Phone number: +49 2103 29 11826. sifilis exame laboratorialWebb28 maj 2024 · Phoebe Loh e-mail: [email protected] +49 2103 29 11711 +49 2103 29 11457. Public Relations Thomas Theuringer Robert Reitze e-mail: [email protected] +49 2103 29 … the powers that be castWebbPhoebe Loh is Senior Dir:Investor Relations at Qiagen NV. See Phoebe Loh's compensation, career history, education, & memberships. sifilis fisterraWebb14 apr. 2024 · Phoebe Loh Senior Director Investor Relations +49 2103 29 11457. [email protected]. Download VCARD. Alexandra Koenig Investor Relations Coordinator +49 2103 29 11709. [email protected]. Download VCARD. John Gilardi Vice President Head of Corporate Communications and Investor Relations sifilis ficha sinanWebb13 apr. 2024 · ^VENLO, Niederlande, April 14, 2024 -- QIAGEN hat heute die Einführung seiner QIAseq Targeted cfDNA Ultra Panels bekannt gegeben. Mit... 14 April 2024 ... Public Relations John Gilardi +49 2103 29 11711 Thomas Theuringer +49 2103 29 11826 Phoebe Loh +49 2103 29 11457 Daniela Eltrop +49 2103 29 11676 E-Mail ... sifilis folleto